Summary

The global halal empty capsules market is projected to surpass USD 1.55 billion in 2029 from USD 1.19 billion in 2024, with a significant CAGR of 5.4%. Increased demand for halal certified products among the end users for pharmaceutical and nutraceutical applications is giving momentum to the market growth. Furthermore, increased investment by key market players in producing halal empty capsules to meet the needs of both local and international markets is further projecting the market growth.
“The gelatin halal empty capsules segment accounted for the largest share in 2023.”
On the basis of type, the halal empty capsules market is further segmented into gelatin and non-gelatin. The gelatin segment dominated the market in 2023, owing to affordability, diversified use and ease of production. Non-gelatin segment is anticipated to grow at significant CAGR due to growing demand for vegetarian and vegan product, availability of halal-certified non-gelatin capsules and favourable regulatory support for non-gelatin capsules.
“By end user, pharmaceutical industry segment accounted for the largest share in the halal empty capsules market.”
The end user segment in the halal empty capsules market is segmented into pharmaceutical industry, Nutraceutical Industry and other end users. The pharmaceutical industry dominated the segment owing to shift of pharmaceutical manufacturers towards halal-certified capsules production to capture a regions/ customer across the globe. Nutraceutical Industry is likely to rapidly due to various factors such as rise in demand for halal-certified supplements and dietary requirements. Furthermore, non-gelatin capsules made from materials such as hydroxypropyl methylcellulose (HPMC) and pullulan are gaining popularity, as they offer suitable alternatives for vegetarians and vegans this is one of the major element likely to upsurge the market growth.
“North America: the largest share of the halal empty capsules market”
By region, the market is segment into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America dominated the halal empty capsules market in 2023 and likely continue dominance during the forecast period. Presence of dominant market players in pharmaceutical and nutraceutical companies in the region, strong base of halal empty capsules manufacturers such as Capsugel (Lonza), Qualicaps, and ACG are some of the prominent factors acerating market growth.
In-depth interviews have been conducted with chief executive officers (CEOs), Directors, and other executives from various key organizations operating in the halal empty capsules market.
The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side- 65% and Demand Side 35%
• By Designation: Managers - 45%, CXO & Directors - 30%, and Executives - 25%
• By Region: North America -40%, Europe -25%, Asia-Pacific -25%, Latin America -5% and Middle East & Africa- 5%
Lonza (Switzerland), ACG (India), Qualicaps (Roquette Freres) (US), Suheung Co. Ltd. (South Korea), Shanxi Guangsheng Capsule Limited (China), CapsCanada (Lyfe Group) (US), HealthCaps India (India), Nector LifeSciences Ltd. (India), Erawat Pharma Limited (India), Qingdao Yiqing Biotechnology Co. Ltd. (China), Fortcaps Healthcare Ltd. (India), Sunil Healthcare (India), and Natural Capsules Limited (India) and SaviourCaps (India) are some of the major players operating in the halal empty capsules market.

Research Coverage:
This research report categorizes the halal empty capsuless market type (gelatin and non-gelatin), End User (pharmaceutical industry, Nutraceutical Industry and other end users) and region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the halal empty capsuless market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products, solutions, key strategies, collaborations, partnerships, and agreements. New launches, collaborations and acquisitions, and recent developments associated with the halal empty capsules market.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the halal empty capsules and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
• Analysis of key drivers (increased demand for halal-certified products in pharmaceutical & nutraceutical industry, customer shift towards clean labels & ethical products), restraints (limited availability of halal-certified raw materials), opportunities (rising demand for non-gelatin/vegetarian capsule) and Challenges (stringent and varying halal certification requirements) influencing the growth of the market.
• Product Development/Innovation: Detailed insights on upcoming technologies in capsules manufacturing, research and development activities, and new product launches in the halal empty capsules market.
• Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the halal empty capsules market
• Competitive Assessment: Lonza (Switzerland), ACG (India), Qualicaps (Roquette Freres) (US), Suheung Co. Ltd. (South Korea), among others in the market.

ページTOPに戻る

Table of Contents

1 INTRODUCTION 16
1.1 STUDY OBJECTIVES 16
1.2 MARKET DEFINITION 16
1.3 MARKET SCOPE 17
1.3.1 MARKETS COVERED 17
1.3.2 INCLUSIONS & EXCLUSIONS 17
1.3.3 YEARS CONSIDERED 18
1.4 CURRENCY CONSIDERED 18
1.5 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH DATA 19
2.1.1 SECONDARY DATA 19
2.1.2 PRIMARY DATA 20
2.2 MARKET SIZE ESTIMATION OF HALAL EMPTY CAPSULES 21
2.2.1 INSIGHTS FROM PRIMARIES 24
2.2.2 TOP-DOWN APPROACH 25
2.3 MARKET GROWTH RATE PROJECTIONS 26
2.4 DATA TRIANGULATION 28
2.5 RESEARCH ASSUMPTIONS 29
2.6 RESEARCH LIMITATIONS 30
2.7 RISK ANALYSIS 30
3 EXECUTIVE SUMMARY 31
4 PREMIUM INSIGHTS 34
4.1 HALAL EMPTY CAPSULES MARKET OVERVIEW 34
4.2 NORTH AMERICA: HALAL EMPTY CAPSULES MARKET SHARE,
BY TYPE & COUNTRY (2023) 35
4.3 HALAL EMPTY CAPSULES MARKET SHARE, BY TYPE, 2023 35
4.4 HALAL EMPTY CAPSULES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
5.2.1 DRIVERS 38
5.2.1.1 Increasing demand for halal-certified products in pharmaceutical & nutraceutical industries 38
5.2.1.2 Consumer shift toward clean labels and ethical products 38
5.2.2 RESTRAINTS 38
5.2.2.1 Limited availability of halal-certified raw materials 38
5.2.3 OPPORTUNITIES 39
5.2.3.1 Rising demand for non-gelatin/vegetarian capsules 39
5.2.4 CHALLENGES 39
5.2.4.1 Stringent and varying halal certification requirements 39
5.3 ECOSYSTEM ANALYSIS 40
5.3.1 RAW MATERIAL SUPPLIERS 40
5.3.2 HALAL EMPTY CAPSULE MANUFACTURERS 41
5.3.3 REGULATORY BODIES AND CERTIFICATION BODIES 41
5.3.4 END USERS 42
5.4 VALUE CHAIN ANALYSIS 42
5.5 SUPPLY CHAIN ANALYSIS 44
5.6 PORTER’S FIVE FORCES ANALYSIS 45
5.6.1 INTENSITY OF COMPETITIVE RIVALRY 46
5.6.2 BARGAINING POWER OF SUPPLIERS 46
5.6.3 BARGAINING POWER OF BUYERS 47
5.6.4 THREAT OF SUBSTITUTES 47
5.6.5 THREAT OF NEW ENTRANTS 47
5.7 KEY STAKEHOLDERS AND BUYING CRITERIA 47
5.7.1 KEY STAKEHOLDERS 47
5.7.2 BUYING CRITERIA 49
5.8 PRICING ANALYSIS 50
5.8.1 AVERAGE SELLING PRICE TREND, BY TYPE 50
5.8.2 AVERAGE SELLING PRICE, BY REGION 51
5.9 REGULATORY LANDSCAPE 51
5.9.1 REGULATORY ANALYSIS 51
5.9.1.1 North America 51
5.9.1.2 Europe 52
5.9.1.3 Asia Pacific 52
5.9.1.4 Latin America 52
5.9.1.5 Middle East & Africa 52
5.9.2 REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 52
5.10 TECHNOLOGY ANALYSIS 55
5.10.1 KEY TECHNOLOGIES 55
5.10.1.1 Automated capsule manufacturing 55
5.10.1.2 Advanced coating technologies 55
5.10.2 ADJACENT TECHNOLOGIES 55
5.10.2.1 3D printing (additive technology) 55
5.10.2.2 Enteric capsule technologies 56
 
5.10.3 COMPLEMENTARY TECHNOLOGIES 56
5.10.3.1 Nanotechnology 56
5.10.3.2 AI in capsule manufacturing 56
5.11 KEY CONFERENCES AND EVENTS, 2024–2025 57
5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 58
5.13 IMPACT OF ARTIFICIAL INTELLIGENCE ON HALAL EMPTY CAPSULES MARKET 59
6 HALAL EMPTY CAPSULES MARKET, BY TYPE 60
6.1 INTRODUCTION 61
6.2 GELATIN HALAL EMPTY CAPSULES 61
6.2.1 DEMAND FOR HALAL GELATIN CAPSULES TO SUPPORT MARKET GROWTH 61
6.3 NON-GELATIN HALAL EMPTY CAPSULES 63
6.3.1 INCREASING PREFERENCE FOR PLANT-BASED PRODUCTS TO DRIVE MARKET 63
7 HALAL EMPTY CAPSULES MARKET, BY END USER 66
7.1 INTRODUCTION 67
7.2 PHARMACEUTICAL INDUSTRY 67
7.2.1 PHARMA SECTOR TO REGISTER HIGHEST DEMAND FOR HALAL EMPTY CAPSULES 67
7.3 NUTRACEUTICAL INDUSTRY 69
7.3.1 RISING PREFERENCE FOR CAPSULE-BASED FORMULATIONS IN KEY REGIONS TO DRIVE MARKET 69
7.4 OTHER END USERS 72
8 HALAL EMPTY CAPSULES MARKET, BY REGION 74
8.1 INTRODUCTION 75
8.2 NORTH AMERICA 75
8.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK 76
8.2.2 US 78
8.2.2.1 US to hold large shares of North American and global markets 78
8.2.3 CANADA 80
8.2.3.1 Shift toward plant-based and sustainable alternatives to drive market 80
8.3 EUROPE 81
8.3.1 EUROPE: MACROECONOMIC OUTLOOK 81
8.3.2 GERMANY 83
8.3.2.1 Germany to account for largest share in Europe 83
8.3.3 UK 84
8.3.3.1 Presence of leading players to boost product access 84
8.3.4 FRANCE 85
8.3.4.1 Ban on bovine-based food-grade gelatin to restrain market 85
8.3.5 ITALY 87
8.3.5.1 Increasing health awareness among consumers to drive market 87
 
8.3.6 SPAIN 88
8.3.6.1 Supportive regulatory frameworks and rising product access to drive market 88
8.3.7 REST OF EUROPE 89
8.4 ASIA PACIFIC 90
8.4.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK 91
8.4.2 CHINA 94
8.4.2.1 Strong presence of raw material providers to drive market 94
8.4.3 INDIA 95
8.4.3.1 Large target population and rising awareness to support market growth 95
8.4.4 JAPAN 96
8.4.4.1 Rising demand for pharma products to propel market 96
8.4.5 REST OF ASIA PACIFIC 97
8.5 LATIN AMERICA 99
8.5.1 RISING HEALTH CONSCIOUSNESS AND GROWING DEMAND TO PROPEL MARKET 99
8.5.2 LATIN AMERICA: MACROECONOMIC OUTLOOK 99
8.6 MIDDLE EAST & AFRICA 101
8.6.1 SUPPORT FOR CERTIFICATION, CULTURAL PREFERENCES,
AND GROWING AWARENESS TO DRIVE MARKET 101
8.6.2 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK 101
9 COMPETITIVE LANDSCAPE 103
9.1 OVERVIEW 103
9.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 103
9.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN HALAL EMPTY CAPSULES MARKET 104
9.3 REVENUE ANALYSIS 105
9.4 MARKET SHARE ANALYSIS 106
9.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 108
9.5.1 STARS 108
9.5.2 EMERGING LEADERS 108
9.5.3 PERVASIVE PLAYERS 108
9.5.4 PARTICIPANTS 108
9.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 110
9.5.5.1 Company footprint 110
9.5.5.2 Type footprint 111
9.5.5.3 End-user footprint 112
9.5.5.4 Region footprint 113
9.6 VALUATION & FINANCIAL METRICS 114
9.6.1 FINANCIAL METRICS 114
9.6.2 COMPANY VALUATION 114
9.7 BRAND/PRODUCT COMPARISON 115
9.8 COMPETITIVE SCENARIO 116
9.8.1 PRODUCT LAUNCHES 116
9.8.2 DEALS 116
9.8.3 EXPANSIONS 117
10 COMPANY PROFILES 118
10.1 KEY PLAYERS 118
10.1.1 LONZA 118
10.1.1.1 Business overview 118
10.1.1.2 Products offered 119
10.1.1.3 Recent developments 121
10.1.1.3.1 Product launches 121
10.1.1.4 MnM view 121
10.1.1.4.1 Key strengths 121
10.1.1.4.2 Strategic choices 121
10.1.1.4.3 Weaknesses and competitive threats 121
10.1.2 ACG 122
10.1.2.1 Business overview 122
10.1.2.2 Products offered 122
10.1.2.3 Recent developments 123
10.1.2.3.1 Deals 123
10.1.2.3.2 Expansions 124
10.1.2.4 MnM view 124
10.1.2.4.1 Key strengths 124
10.1.2.4.2 Strategic choices 124
10.1.2.4.3 Weaknesses and competitive threats 124
10.1.3 SUHEUNG CO., LTD. 125
10.1.3.1 Business overview 125
10.1.3.2 Products offered 126
10.1.3.3 MnM view 127
10.1.3.3.1 Key strengths 127
10.1.3.3.2 Strategic choices 127
10.1.3.3.3 Weaknesses and competitive threats 127
10.1.4 QUALICAPS (ROQUETTE FRÈRES) 128
10.1.4.1 Business overview 128
10.1.4.2 Products offered 128
10.1.4.3 Recent developments 129
10.1.4.3.1 Deals 129
10.1.4.3.2 Expansions 129
 
10.1.5 SHANXI GUANGSHENG CAPSULE LIMITED 130
10.1.5.1 Business overview 130
10.1.5.2 Products offered 130
10.1.6 CAPSCANADA (LYFE GROUP) 131
10.1.6.1 Business overview 131
10.1.6.2 Products offered 131
10.1.7 HEALTHCAPS INDIA 132
10.1.7.1 Business overview 132
10.1.7.2 Products offered 133
10.1.8 NECTAR LIFESCIENCES LTD. 134
10.1.8.1 Business overview 134
10.1.8.2 Products offered 135
10.1.9 SUNIL HEALTHCARE LIMITED 136
10.1.9.1 Business overview 136
10.1.9.2 Products offered 138
10.1.10 FARMACÁPSULAS 139
10.1.10.1 Business overview 139
10.1.10.2 Products offered 139
10.1.11 NATURAL CAPSULES LIMITED 140
10.1.11.1 Business overview 140
10.1.11.2 Products offered 141
10.1.12 ERAWAT PHARMA LIMITED 142
10.1.12.1 Business overview 142
10.1.12.2 Products offered 143
10.1.13 QINGDAO YIQING BIOTECHNOLOGY CO., LTD. 144
10.1.13.1 Business overview 144
10.1.13.2 Products offered 144
10.1.14 FORTCAPS (KUMAR ORGANIC PRODUCTS LIMITED) 145
10.1.14.1 Business overview 145
10.1.14.2 Products offered 145
10.1.14.3 Recent developments 146
10.1.14.3.1 Deals 146
10.1.15 SAVIOUR CAPS PVT. LTD. 147
10.1.15.1 Business overview 147
10.1.15.2 Products offered 147
11 APPENDIX 148
11.1 DISCUSSION GUIDE 148
11.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 151
11.3 CUSTOMIZATION OPTIONS 153
11.4 RELATED REPORTS 153
11.5 AUTHOR DETAILS 154